>>> US Research Calls I

Research Calls I
  • Upgrades:
    • Banc of California (BANC) upgraded to Overweight from Equal Weight at Barclays; tgt raised to $18
    • Danaher (DHR) upgraded to Outperform from Peer Perform at Wolfe Research; tgt $285
    • Envista (NVST) upgraded to Market Perform from Underperform at Leerink Partners; tgt raised to $23
    • KLA Corporation (KLAC) upgraded to Outperform from Perform at Oppenheimer; tgt raised to $850
    • L3Harris (LHX) upgraded to Buy from Neutral at BofA Securities; tgt $300
    • Meritage (MTH) upgraded to Buy from Neutral at Goldman; tgt raised to $235
    • Omega Health (OHI) upgraded to Outperform from Neutral at Exane BNP Paribas; tgt $49
    • Regions Fincl (RF) upgraded to Outperform from Mkt Perform at Keefe Bruyette; tgt raised to $28
    • Smurfit Westrock plc (SW) upgraded to Outperform from Sector Perform at RBC Capital Mkts; tgt raised to $58
    • Valley National (VLY) upgraded to Equal Weight from Underweight at Barclays; tgt raised to $10
    • Wingstop (WING) upgraded to Buy from Neutral at BTIG Research; tgt $370
  • Downgrades:
    • Arm Holdings plc (ARM) downgraded to Underperform from Mkt Perform at Bernstein; tgt $100
    • Biogen (BIIB) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt lowered to $204
    • Blackbaud (BLKB) downgraded to Neutral from Outperform at Robert W. Baird; tgt lowered to $80
    • Brinker (EAT) downgraded to Market Perform from Outperform at BMO Capital Markets; tgt raised to $105
    • Brinker (EAT) downgraded to Neutral from Overweight at JP Morgan; tgt raised to $100
    • FirstEnergy (FE) downgraded to Neutral from Buy at Seaport Research Partners
    • First Interstate Bancsystem (FIBK) downgraded to Underweight from Equal Weight at Barclays; tgt lowered to $30
    • GlaxoSmithKline (GSK) downgraded to Neutral from Buy at Guggenheim
    • Kraft Heinz (KHC) downgraded to Hold from Buy at Deutsche Bank; tgt lowered to $35
    • Option Care Health (OPCH) downgraded to Hold from Buy at Jefferies; tgt lowered to $26
    • TE Connectivity (TEL) downgraded to Reduce from Hold at HSBC Securities; tgt $137
    • Trane (TT) downgraded to Hold from Buy at HSBC Securities; tgt $405
  • Others:
    • Alumis (ALMS) initiated with an Outperform at Robert W. Baird; tgt $25
    • Enliven Therapeutics (ELVN) initiated with a Buy at JonesResearch
    • ORIC Pharmaceuticals (ORIC) initiated with an Overweight at Wells Fargo; tgt $20
    • ORIC Pharmaceuticals (ORIC) initiated with a Buy at JonesResearch
    • Terns Pharmaceuticals (TERN) initiated with an Outperform at Oppenheimer; tgt $82
    • Vanda Pharma (VNDA) initiated with a Buy at H.C. Wainwright; tgt $18